CPNG Adjusted EBITDA Grew 28% - Net Income Fell 95%. Which One Is the Real Story?

A Year Where the Adjusted Numbers and the GAAP Numbers Tell Opposite Stories

Coupang's full-year 2024 net income came in at $66 million, down 95% from 2023's $1.36 billion. Read alone, that looks like a business in retreat. It isn't - it's a comparison built on two distortions that mostly cancel each other out in the wrong direction. 2023's post already flagged that $905 million of that $1.36 billion was a one-time Korean deferred-tax valuation-allowance release, putting normalized 2023 net income closer to $455 million. Against that more honest baseline, 2024's $66 million is still down roughly 85% - but the reasons are now real, one-time, and disclosed rather than accounting noise: a $121 million KFTC administrative fine accrued in the second quarter, plus a full first year of Farfetch's losses (Farfetch itself lost $352 million from its January 30, 2024 acquisition date through year-end) with essentially zero offsetting tax benefit, since Farfetch's losses sit behind a valuation allowance of their own.

Move down to Adjusted EBITDA, and the story inverts completely: $1.375 billion, up 28% from $1.074 billion, with the margin edging up from 4.4% to 4.5% even with Farfetch's drag included. Product Commerce's own Segment Adjusted EBITDA grew 30% to $2.006 billion, and its margin for the full year expanded to 7.5% from 6.5% a year earlier - a genuine improvement, not an artifact, even after Q3's well-flagged margin giveback to 6.8%. The retail engine had a better year in 2024 than in 2023 on every operating measure that matters; the GAAP bottom line just absorbed a regulatory fine and an acquisition's teething losses on top of it.

The year's real turning point was the quarter this filing lets a reader isolate for the first time: subtracting the nine months this site already tracked from full-year totals, Q4 2024 was Coupang's best quarter of the year on nearly every measure - revenue of $7.965 billion, Adjusted EBITDA of $421 million (a 5.3% margin, the year's high), operating income of $312 million, net income of $131 million, and free cash flow that rebounded to roughly $463 million from Q3's negative $42 million. Some of that is a one-time boost: a long-pending $175 million insurance gain from a fulfillment-center fire that happened in June 2021 finally landed this quarter (see Beyond the Usual below) - but even backing that out, Q4's underlying trajectory was still the year's strongest, and it's the quarter that answers last quarter's open question about capex: Q3's capex roughly doubled to $380 million and free cash flow swung negative; full-year capex of $879 million actually came in below 2023's $896 million, meaning Q4's capital spending fell back sharply and the elevated Q3 cadence was the one-quarter cluster this site's base case hoped for, not a new normal.

The Prescription

Coupang should start reporting Farfetch's contribution as a standing line in its own segment disclosure rather than requiring a reader to reconstruct it from an acquisition footnote each time. This filing shows Farfetch added $1.658 billion of revenue and a $352 million net loss for the ten-plus months it's been consolidated - genuinely useful numbers that are currently scattered across the MD&A, the segment note, and Note 16, none of which cross-reference each other cleanly. A pro forma table already exists (full-year 2024 pro forma net loss of $20 million versus 2023's pro forma $965 million profit) - the company clearly has the internal reporting to isolate Farfetch's drag; it should just show its work in one place every quarter, not just once a year.

What it should stop doing: treating the Farfetch/New Guards internal-controls material weakness as a footnote-level disclosure rather than a headline risk. This filing states plainly that a material weakness Farfetch Limited itself disclosed for 2022 - covering IT and business-process controls in the New Guards business - was "not fully remediated as of December 31, 2024," a full year after acquisition (see Beyond the Usual below). Coupang is entitled to exclude Farfetch from its own internal-controls assessment for one transition year under SEC guidance, but a reader shouldn't have to know that rule exists to understand that the numbers behind roughly 5% of consolidated revenue currently rest on controls the company itself says aren't fixed yet.

Key Financial Metrics

FY2024 vs. FY2023 - reported in USD, full-year figures from this 10-K's consolidated financial statements

Coupang reports natively in US dollars, so no FX conversion is needed here. Figures are drawn directly from this 10-K's consolidated financial statements and MD&A tables, covering the fiscal year ended December 31, 2024.

Metric	FY2024	FY2023	YoY
Total net revenues	$30,268M	$24,383M	✅ +24% (+29% constant currency)
Gross profit	$8,831M	$6,190M	✅ +43%, margin 29.2% vs 25.4%
Operating income	$436M	$473M	⚠️ -8%, on the KFTC fine and Farfetch costs
Adjusted EBITDA»	$1,375M	$1,074M	✅ +28%, margin 4.5% vs 4.4%
Income before income taxes	$473M	$584M	⚠️ -19%
Income tax expense (benefit)	$407M	$(776)M	⚠️ 2023 included a one-time $905M valuation-allowance release
Net income (consolidated)	$66M	$1,360M	⚠️ -95%, but 2023's figure was inflated - see above
Net income attributable to Coupang stockholders	$154M	$1,360M	⚠️ noncontrolling interests absorbed an $88M loss this year
Net cash provided by operating activities	$1,886M	$2,652M	⚠️ -29%, on lower net income and working-capital timing
Free cash flow»	$1,016M	$1,775M	⚠️ -43%, though still solidly positive for the year
Cash & cash equivalents (period end)	$5,879M	$5,243M	✅ +12%

Balance sheet metric	Dec 2024	Dec 2023	Change
Total assets	$15,344M	$13,346M	✅ +15.0%
Total liabilities	$11,167M	$9,242M	⚠️ +20.8%
Total equity	$4,102M	$4,089M	✅ +0.3%, essentially flat
Redeemable noncontrolling interest	$75M	$15M	⚠️ +$60M on Greenoaks' further capital contribution - see below

Total short- and long-term debt (short-term borrowings, current portion of long-term debt, and long-term debt) came to $1.533 billion at year-end, up from $1.014 billion a year earlier - almost entirely the Farfetch Term Loans ($493 million outstanding) assumed with the acquisition, since Coupang's own pre-existing debt barely moved. Q4-only figures, derived by subtracting the nine months already reported from this filing's full-year totals: revenue of $7,965 million, Adjusted EBITDA of $421 million (margin 5.3%, the year's best), operating income of $312 million, net income of $131 million, and free cash flow of roughly $463 million - a clean rebound across the board from Q3, though the insurance gain flatters several of these (see above).

Segment Performance: Product Commerce vs. Developing Offerings

Coupang reports the same two segments as every quarter since Q1 2022: Product Commerce (core retail, marketplace, Rocket Fresh, and related advertising) and Developing Offerings (Coupang Eats, Coupang Play, Taiwan retail, fintech, and, since Q1 2024, Farfetch).

Metric	Product Commerce FY2024	Product Commerce FY2023	Developing Offerings FY2024	Developing Offerings FY2023
Net revenues	$26,699M	$23,594M	$3,569M	$789M
Revenue growth	✅ +13% (+18% constant currency)	—	✅ +352% (mostly Farfetch)	—
Segment Adjusted EBITDA	✅ $2,006M (margin 7.5%)	$1,540M (margin 6.5%)	⚠️ $(631)M (margin -17.7%)	$(466)M (margin -59.1%)

Product Commerce had a genuinely strong year: Segment Adjusted EBITDA grew 30% to $2.006 billion and margin expanded a full percentage point to 7.5%, even carrying Q3's sequential dip to 6.8% inside that average. The quarterly trend this site has now tracked across four quarters - 7.2% (Q1), 8.2% (Q2, still the record), 6.8% (Q3), and an implied 7.83% in Q4 (derived from full-year totals minus the first three quarters) - shows the segment settling into a high-6s-to-8% range rather than a single clean upward line, but every one of those quarters beat 2023's full-year average. This is the one part of the business compounding cleanly, quarter of noise notwithstanding.

Developing Offerings' dollar loss widened 35% to $(631) million for the year, but the composition changed meaningfully: Farfetch itself posted an Adjusted EBITDA loss of only $34 million for 2024 (a fraction of its $352 million GAAP net loss, since Adjusted EBITDA strips out the depreciation, amortization, and interest that come with a leveraged acquisition), with the rest of the segment's widened loss coming from "increased investments in Taiwan offerings, higher content costs for our Coupang Play offering," partially offset by improved profitability at Coupang Eats. Implied Q4 loss (derived from full-year totals minus the first three quarters) was $(118) million on $1,082 million of revenue - a margin of -10.9%, the segment's best quarterly margin of the year by a wide margin, consistent with the same fourth-quarter strength showing up across the consolidated numbers.

Key Operational Metrics

Quarter	Product Commerce Active Customers	Net revenues per Product Commerce Active Customer
Dec 2023	20.8M	$302
Mar 2024	21.5M	$302
Jun 2024	21.7M	$296
Sep 2024	22.5M	$307
Dec 2024	22.8M	$302

Product Commerce Active Customers^» grew 10% YoY to a new full-year high of 22.8 million, adding 0.3 million sequentially in Q4 - the smallest quarterly add of the year, a deceleration worth watching next year even though the absolute base kept growing. Revenue per customer dipped slightly to $302 from Q3's $307 high but matched Q1's level and beat every quarter of 2023 - both measures ended the year at or near their best levels, even with Q4's growth pace cooling.

"Not available" again this filing: orders per customer, Rocket WOW membership subscriber count, and third-party seller/merchant count - none disclosed, consistent with every prior quarter this site has tracked.

Beyond the Usual

An unremediated material weakness sits inside the numbers Coupang chose not to audit for a year

This filing discloses, for the first time, that Farfetch Limited itself identified material weaknesses in its internal control over financial reporting for the year ended December 31, 2022 - specifically covering "the operating effectiveness of certain business process and information technology controls in the New Guards business," the same Farfetch subsidiary behind the Reebok license dispute flagged last quarter. Coupang states plainly that this weakness "was not fully remediated as of December 31, 2024," more than eleven months after the acquisition closed. Under SEC guidance, an acquirer may exclude a newly-acquired business from its own internal-controls assessment for the first year after close - which is exactly what Coupang did, excluding Farfetch (roughly 7% of consolidated assets and 5% of consolidated revenue) from both its disclosure-controls and internal-controls conclusions for 2024. That exclusion is standard practice, not a violation on its own - but it means a full year of Farfetch's contribution to Coupang's consolidated financials was never actually assessed against Coupang's own control standard, and the underlying weakness the company inherited still isn't fixed. Remediation is described only as "actively engaged," with no target date given.

A full year of KFTC litigation ended with the fine being paid and the underlying case still unresolved

The KFTC matter tracked across five prior filings moved through a complete cycle this year without resolving. Coupang Corp. and CPLB received the KFTC's formal written decision in August 2024, appealed in September, and the first hearing of the administrative litigation was held in November 2024 (a second hearing is scheduled for the end of March 2025). In October 2024, the Seoul High Court granted a stay of the KFTC's corrective orders but denied a stay of the $121 million fine itself, so Coupang Corp. began paying the fine in installments (the first payment made in October 2024, the last due June 2026) even while the underlying finding is still being actively litigated. Separately, in November 2024 - in response to the KFTC's original criminal referral - the Seoul Eastern District Prosecutors' Office opened a formal criminal investigation into Coupang Corp. and CPLB, a new and more serious front than the civil appeal alone. As a subsequent event, the KFTC appealed the Seoul High Court's decision to grant the corrective-orders stay, and in February 2025 Korea's Supreme Court dismissed that appeal - a genuine win for Coupang procedurally, though it resolves nothing about the underlying search-rankings finding itself, which remains under appeal with no resolution date. The KFTC's separate, broader investigation into "other matters" related to the same alleged violations also remains open with no estimate of additional exposure, identical unresolved-scope language to every prior filing this site has tracked.

Greenoaks Capital Partners was renamed after three quarters of silence - restoring disclosure of the board member who sits on both sides of the deal

Three straight quarterly filings dropped the naming of Greenoaks Capital Partners, LLC as the co-investor holding a 19.9% stake in Surpique LP, the vehicle used to acquire Farfetch - a regression from the FY2023 10-K's original disclosure, which had already named both Greenoaks and Neil Mehta, a member of Coupang's own Board of Directors, who has served as a Managing Partner of Greenoaks since April 2012. This annual filing restores the naming of both the firm and Mr. Mehta, and adds detail the original disclosure didn't have: Greenoaks contributed a further $55 million during 2024 toward the acquisition, and the redeemable noncontrolling interest's estimated redemption value is now $100 million as of year-end (against a $75 million carrying value). None of this makes the arrangement improper - the put/call option terms and consolidation treatment are laid out plainly, and a board member co-investing through a firm he manages has now been disclosed twice, not hidden - but three quarters of silence on a director sitting on both sides of a related-party equity stake in a $208 million acquisition is exactly the kind of disclosure gap this site flagged as a governance issue when the acquisition was first announced. Worth watching whether next year's filings keep naming both the firm and the individual consistently, rather than letting the disclosure lapse again.

The Reebok license dispute flagged last quarter was resolved without any cash payment changing hands

Last quarter's post flagged a Farfetch subsidiary's licensor disputing $312 million of accelerated payments after terminating a Reebok distribution license. This filing discloses the resolution as a subsequent event: in February 2025, New Guards Group Holdings S.p.A. and Authentic Brands Group LLC entered into a Mutual Termination Agreement, under which NGGH's distribution rights and the licensor's right to the remaining $264 million of minimum guaranteed royalties were both terminated - in exchange for NGGH transferring inventory and certain working capital balances to a new licensee, rather than any cash settlement. NGGH also agreed to provide transition services to the new licensee through April 2025, with the new licensee reimbursing those costs. The dispute that could have cost NGGH up to $312 million on top of its existing $136 million carrying liability closed out as an inventory transfer instead - a materially better outcome than the range flagged last quarter, though still contained to the Farfetch subsidiary rather than touching the parent, exactly as Coupang originally framed it.

A fulfillment-center fire from June 2021 finally produced a settled insurance recovery this quarter: Coupang recognized a $175 million gain in Q4 2024 ($116 million against the inventory loss in cost of sales, $59 million against property-and-equipment loss in operating expenses) after agreeing to a partial settlement and deeming further recovery probable, on top of $178 million in provisional payments received in prior years. Whether additional recoveries beyond this settlement will materialize is still unknown - a three-and-a-half-year gap between loss and settled recovery is a useful data point on how long an insured casualty claim can sit unresolved on a company's books.

Coupang disclosed $2.436 billion of undiscounted unconditional purchase obligations due through 2029 and beyond (primarily technology service contracts, fulfillment-center construction, and software licenses), plus $215 million of future minimum lease payments for operating leases that hadn't yet commenced as of year-end - neither shows up on the balance sheet today, but both represent real multi-year commitments a reader wouldn't see from the income statement alone. Confirmed obligations under Coupang's supplier-financing (reverse-factoring) program, sitting inside accounts payable rather than a labeled debt line, actually fell to $443 million at year-end from $459 million at the start of 2024, a rare full-year decline in this off-balance-sheet-flavored obligation after several quarters of growth.

In January 2025, the Farfetch Term Loans were amended to waive technical defaults arising from Coupang's own restructuring of Farfetch's Italian subsidiaries - meaning the restructuring actions Coupang undertook to integrate Farfetch (reducing headcount, exiting leases and licensing agreements) themselves triggered a default under debt Coupang had assumed, requiring a lender waiver and a partial prepayment (up to $125 million) from Italian VAT-receivable proceeds. Coupang states it has provided no security or guaranty on these loans and isn't obligated to fund Farfetch beyond its share of Surpique LP's remaining $148 million commitment - a useful reminder that the Farfetch Term Loans, unlike Coupang's own debt, are legally ring-fenced to the acquired entity.

The Choi v. Coupang securities class action tracked across every prior filing remains open with no lead plaintiff named. The litigation footprint around it grew this year: a fourth stockholder derivative action was filed in Delaware Chancery Court in December 2024 (joining three prior derivative suits in the Southern District of New York), and as a subsequent event, Coupang received two Board demands in February 2025 alleging claims similar to the class and derivative actions and demanding the Board pursue civil action against certain current and former directors and officers - a new escalation path beyond the existing lawsuits, with those demands now before the Board for evaluation.

Target Valuation Range

EV $35.1 billion, ~1.16x EV/Revenue. Bottom line: Coupang's EV/Revenue multiple compressed to roughly 1.16x at year-end, down from Q3's ~1.26-1.38x range - the stock gave back its Q4 rally into the year-end close even as Q4 turned in the year's strongest operating quarter, meaning the market moved in the opposite direction from the fundamentals for once.

Coupang closed FY2024 (December 31, 2024, the last trading day of the year) at $21.98, down 10.5% from $24.55 at Q3's close but up 35.8% from $16.19 a year earlier. The stock actually peaked at $25.79 in October 2024 before pulling back roughly 15% into year-end - a genuine round-trip within the quarter that a reader comparing only quarter-end prices would miss entirely. With approximately 1,643 million Class A shares and 158 million Class B shares outstanding (1,801 million total) as of December 31, 2024, that implies a market capitalization of approximately $39.6 billion, up from $44.2 billion at Q3's close on the lower share price.

Using cash, cash equivalents, and restricted cash of $6.031 billion against total debt of approximately $1.533 billion, net cash comes to roughly $4.498 billion, putting enterprise value at approximately $35.1 billion.

Market cap → enterprise value	Q4 2024
Share price (period-end)	$21.98
Shares outstanding (Class A + B)	1,801 million
Market capitalization	$39.6 billion
Net cash (cash & equivalents less total debt)	$4.498 billion
Enterprise value	$35.1 billion

EV/Revenue sanity check	Q3 2024	Q4 2024	Change
Enterprise value	$39.8 billion	$35.1 billion	down
EV/Revenue	1.38x	1.16x	down

• EV/Revenue^» using FY2024's full-year revenue ($30.268 billion): ~1.16x, down from Q3's ~1.38x on a trailing-twelve-months basis - the multiple's brief climb above 1.25x didn't hold through year-end.

DCF and reverse DCF (illustrative only): sixteen quarters of public-company data now cover Q3 2021 through Q4 2024. Checking this year against Q3 2024's base case:

Scenario	Assumption / outcome
Current (period-end close)	Actual EV/Revenue this quarter, for reference: 1.16x
Q3 2024 base case	The Q3 2024 base case called for Product Commerce's margin to stabilize between 6.8% and Q2's 8.2% high, free cash flow to return to positive as elevated capex proved to be a one-quarter cluster, the KFTC appeal to proceed through its November hearing without new cash outflow beyond the fine already being paid, and the multiple to hold roughly in the 1.25-1.4x range. Product Commerce's margin did stabilize inside that range (7.83% implied for Q4). Free cash flow did return to positive - strongly, at roughly $463 million for the quarter - and capex did prove to be a one-quarter cluster, exactly as hoped. The KFTC appeal proceeded through its hearing without a new direct cash outflow, though a new criminal investigation opened in parallel. The multiple, however, didn't hold the 1.25-1.4x range - it compressed to roughly 1.16x, below even the bear case's implied floor, on the stock's post-October pullback rather than anything in the fundamentals.
Bear case for next year	Bear case for next year: the KFTC's pending March 2025 hearing and the ongoing criminal investigation produce an adverse ruling or a formal indictment, the Farfetch/New Guards material weakness remains unremediated into a second year, Product Commerce's margin slides back toward the low-7s, and the multiple stays compressed below 1.2x on regulatory and governance overhang.
Base case for next year	Base case for next year: the KFTC appeal continues without a near-term ruling either way, the material weakness gets substantively remediated during 2025 (the transition-year exclusion no longer applies), Product Commerce's margin holds in the 7-8% range it settled into this year, and the multiple recovers back toward the 1.25-1.4x range Q3 briefly established.
Bull case for next year	Bull case for next year: the KFTC matter reaches a favorable resolution or a settlement that removes the criminal-referral overhang, Farfetch's Adjusted EBITDA loss (already down to $34 million for the year) turns positive, Product Commerce's margin pushes past Q2's 8.2% high on a full year of FLC and mix-shift benefits, and the multiple re-rates above 1.4x on evidence the acquisition has become genuinely accretive.

---